by Jordan Schachtel at The Dossier
Almost $57 billion of those dollars came directly from grants delivered by the U.S. government for the mRNA shots and Pfizer’s Paxlovid horse pills, the Covid-19 “treatment” best known for its “Paxlovid Rebound” side effects.
Now, the good news.
Pfizer projects a massive decline in revenue to for 2023 to between $67 billion and $71 billion, as the government purchase orders for Pfizer’s failed and dangerous experimental drugs are expected to be drastically reduced. Without another blank check from the Biden Administration, Pfizer expects to sell just $13.5 billion of its mRNA shots and $8 billion of the Paxlovid pills this year…